Author: Ken Dropiewski

Valbiotis Announces That It Has Submitted to the Competent Authorities the Three Clinical Protocols for TOTUM•854 Indicated in the Reduction of Blood Pressure and Presents Its Comprehensive Clinical Development Plan

The INSIGHT international, multicenter, randomized, placebo-controlled pivotal Phase II/III clinical study will be conducted with a 3.7 g/day dose of TOTUM•854 on 400 volunteers; The INSIGHT 2 international, multicenter, randomized, placebo-controlled Phase II/III clinical study will be conducted with a 2.6 g/day dose of TOTUM•854 on 400 volunteers; The clinical […]

Munich Re, Canada (Life) and Heart & Stroke Join Forces in the Fight Against Cardiovascular Disease

Commence a strategic partnership to advance women’s heart and brain health through awareness and prevention TORONTO–(BUSINESS WIRE)–Munich Reinsurance Company’s Canadian life branch (Munich Re) today announced a strategic partnership with Heart & Stroke reinforcing its commitment to combatting cardiovascular disease. With this partnership, Munich Re will provide financial support for […]

Artio Medical’s Amplifi™ Vein Dilation System Demonstrates Encouraging Clinical Results for Hemodialysis Patients Requiring Vascular Access

PRAIRIE VILLAGE, Kan., Nov. 30, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that full results from its first-in-human (FIH) clinical study of the Amplifi™ Vein Dilation System were presented at the 2021 VEITH Symposium by Surendra Shenoy, MD-PhD, […]

Robocath successfully completes first robotic coronary angioplasty with R‑One in China

Rouen, France, November 30, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform. The procedure took place at the 301 Hospital in Beijing on […]

Neovasc Reducer™ System Receives National Reimbursement in France

First therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ (“Reducer”) system has been granted Prise en Charge Transitoire (“PECT”) reimbursement in France by the national health authority, Haute Autorité de Santé (“HAS”). The decision […]

Eko and the National Association of Free & Charitable Clinics Partner to Improve Cardiovascular Care in Medically Underserved Communities

Eko donates smart stethoscope and telehealth kits to free & charitable clinics across 33 states, enhancing cardiac screening services to uninsured and medically underserved Americans OAKLAND, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced its partnership with the National Association of Free & Charitable Clinics (NAFC). […]

Mount Sinai Study Validates DiA’s Cardiac Ultrasound AI Algorithm, Finding it Comparable to Cardiac MRI

Study results demonstrate the accuracy of AI-based ultrasound software, enabling a quicker detection of right ventricle dysfunction caused by COVID-19, pulmonary embolism, and more BE’ER SHEVA, Israel, Nov. 30, 2021 /PRNewswire/ — DiA Imaging Analysis, the leading provider of advanced AI-based software for ultrasound analysis, was featured in a recent study presented by a […]

Soundbite Medical Announces Issuance Of A Fifth U.S. Patent Covering Novel Active Balloon Devices Intended For Plaque Modification Of Calcified Arteries

MONTREAL–(BUSINESS WIRE)–Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued US patent No. 11,179,169, entitled “Device for delivering mechanical waves through a balloon catheter”. […]

BD Names Dr. Joseph M. Smith as Chief Scientific Officer

Digital Health Pioneer to Focus on External Innovation; Becomes Co-Chair of BD Scientific Advisory Board FRANKLIN LAKES, N.J., Nov. 29, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific officer for the […]

Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer

CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc., (Nasdaq: VERV), a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Allison Dorval has been appointed as chief financial officer. Ms. Dorval joins Verve from Voyager Therapeutics and […]